These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18262304)

  • 41. Glycemic treatment in type 1 and type 2 diabetes.
    Bloomgarden ZT
    Diabetes Care; 2006 Nov; 29(11):2549-55. PubMed ID: 17065700
    [No Abstract]   [Full Text] [Related]  

  • 42. Strict glucose control: where are we now?
    Padkin A
    Resuscitation; 2007 Jul; 74(1):194-6. PubMed ID: 17521795
    [No Abstract]   [Full Text] [Related]  

  • 43. Intensive glycemic control in diabetic pregnancy with intrauterine growth restriction is detrimental to fetus.
    Parikh RM; Joshi SR; Menon PS; Shah NS
    Med Hypotheses; 2007; 69(1):203-5. PubMed ID: 17141966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medical evaluation and treatment of diabetic peripheral neuropathy.
    Petit WA; Upender RP
    Clin Podiatr Med Surg; 2003 Oct; 20(4):671-88. PubMed ID: 14636032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of improved glycemic control on complications in type 2 diabetes.
    Gaster B; Hirsch IB
    Arch Intern Med; 1998 Jan; 158(2):134-40. PubMed ID: 9448551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of strict control of blood glucose and nerve function.
    Ward JD
    Clin Physiol; 1985; 5 Suppl 5():85-9. PubMed ID: 3914391
    [No Abstract]   [Full Text] [Related]  

  • 47. Short-term effects of improved glycemic control on cognitive function in patients with type 2 diabetes.
    Hewer W; Mussell M; Rist F; Kulzer B; Bergis K
    Gerontology; 2003; 49(2):86-92. PubMed ID: 12574669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of peripheral nerve fatigue following vibratory stimulation with hyperglycemia in diabetic patients.
    Noda K; Umeda F; Asou N; Motomatu T; Nawata H
    Diabetes Res Clin Pract; 1994 Aug; 25(1):27-33. PubMed ID: 7835209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycemic exposure, glycemic control, and metabolic karma in diabetic complications.
    Thomas MC
    Adv Chronic Kidney Dis; 2014 May; 21(3):311-7. PubMed ID: 24780460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of a single drip infusion of lipo-prostaglandin E1 on vibratory threshold in patients with diabetic neuropathy.
    Tawata M; Nitta K; Kurihara A; Nagasaka T; Iwase E; Gan N; Inoue M; Onaya T
    Prostaglandins; 1995 Jan; 49(1):27-39. PubMed ID: 7792389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of age and diabetes mellitus on nerve function.
    Maser RE; Laudadio C; DeCherney GS
    J Am Geriatr Soc; 1993 Nov; 41(11):1202-4. PubMed ID: 8227894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute exacerbation of chronic osteomyelitis triggered by aggravation of type 2 diabetes mellitus: a case report.
    Irie S; Anno T; Kawasaki F; Shigemoto R; Kaneto H; Kaku K; Okimoto N
    J Med Case Rep; 2019 Jan; 13(1):7. PubMed ID: 30621795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diabetes mellitus in the elderly: succinic acid compounds in treating diabetic neuropathies].
    Odin VI; Belikova TV; Pushkova ES
    Adv Gerontol; 2002; 9():83-7. PubMed ID: 12096444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered taste sensation in newly-diagnosed NIDDM.
    Perros P; MacFarlane TW; Counsell C; Frier BM
    Diabetes Care; 1996 Jul; 19(7):768-70. PubMed ID: 8799637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of goshajinkigan, a herbal medicine, on subjective symptoms and vibratory threshold in patients with diabetic neuropathy.
    Tawata M; Kurihara A; Nitta K; Iwase E; Gan N; Onaya T
    Diabetes Res Clin Pract; 1994 Dec; 26(2):121-8. PubMed ID: 7705193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ASHP therapeutic position statement on strict glycemic control in patients with diabetes.
    American Society of Health-System Pharmacists
    Am J Health Syst Pharm; 2003 Nov; 60(22):2357-62. PubMed ID: 14652987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control.
    Miranda-Massari JR; Gonzalez MJ; Jimenez FJ; Allende-Vigo MZ; Duconge J
    Curr Clin Pharmacol; 2011 Nov; 6(4):260-73. PubMed ID: 22082324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetic neuropathy in elderly Type 2 diabetic patients: effects of insulin treatment.
    Tovi J; Svanborg E; Nilsson BY; Engfeldt P
    Acta Neurol Scand; 1998 Nov; 98(5):346-53. PubMed ID: 9858106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Studies on the vibratory sensation of the skin].
    Watanabe S
    Nihon Jibiinkoka Gakkai Kaiho; 1969 Jan; 72(1):84-102. PubMed ID: 5814327
    [No Abstract]   [Full Text] [Related]  

  • 60. [Neuron damage in diabetes mellitus: study of the possible factors involved and the therapeutic problem].
    Amabile G; Parisi L; Bianco F
    Clin Ter; 1979 Dec; 91(5):537-42. PubMed ID: 397035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.